Protein C levels as a prognostic indicator of outcome in sepsis and related diseases

被引:176
作者
Fisher, CJ [1 ]
Yan, SB [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
protein C; activated protein C; sepsis; coagulation; inflammation; prognostic indicator;
D O I
10.1097/00003246-200009001-00011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To consider the appropriateness of protein C levels as a prognostic indicator for sepsis and related diseases. Data Sources/Study Selection: Published research and review articles related to protein C deficiency in patients with sepsis and related diseases. Data Extraction and Synthesis: All applicable data were extracted, and relevant literature was cited to support factual statements in the text. The protein C pathway represents one of the major regulatory systems of hemostasis, exhibiting antithrombotic, profibrinolytic, and anti-inflammatory properties. Numerous studies have shown that acquired protein C deficiency is prevalent in the majority of septic patients (>85%) and is associated with increased morbidity and mortality in patients with severe sepsis and septic shock. This deficiency in protein C is not simply a transient marker for sepsis, but parallels the progress of the disease. In addition, protein C deficiency occurs in the presence of a wide range of pathogens and develops early in the disease process. Conclusions: A review of tbe relevant literature suggests that protein C levels may serve as a useful prognostic indicator of outcome in sepsis and related diseases.
引用
收藏
页码:S49 / S56
页数:8
相关论文
共 126 条
  • [1] ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95
  • [2] [Anonymous], 1998, Intensive Care Medicine
  • [3] [Anonymous], MMWR
  • [4] Sepsis and septic shock: Pro-inflammatory or anti-inflammatory state?
    Antonelli, M
    [J]. JOURNAL OF CHEMOTHERAPY, 1999, 11 (06) : 536 - 540
  • [5] AOKI N, 1998, J NEW REMEDIES CLIN, V47, P88
  • [6] Severe protein C deficiency, predictor of lethal outcome in meningococcal septicaemia.
    Aronis, S
    Hatzis, A
    Platokouki, H
    Briasoulis, G
    Pergantou, H
    Narlioglou, M
    [J]. PEDIATRIC RESEARCH, 1999, 45 (05) : 765 - 765
  • [7] Asaka S, 1996, LIVER, V16, P183
  • [8] DISSEMINATED INTRAVASCULAR COAGULATION IN POST-DYSENTERIC HEMOLYTIC UREMIC SYNDROME
    BADAMI, KG
    SRIVASTAVA, RN
    KUMAR, R
    SARAYA, AK
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1987, 76 (06): : 919 - 922
  • [9] The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent
    Bajzar, L
    Nesheim, ME
    Tracy, PB
    [J]. BLOOD, 1996, 88 (06) : 2093 - 2100
  • [10] The effects of ibuprofen on the physiology and survival of patients with sepsis
    Bernard, GR
    Wheeler, AP
    Russell, JA
    Schein, R
    Summer, WR
    Steinberg, KP
    Fulkerson, WJ
    Wright, PE
    Christman, BW
    Dupont, WD
    Higgins, SB
    Swindell, BB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) : 912 - 918